Kura Oncology, Inc. Business Finance Contracts & Agreements
32 Contracts & Agreements
- Credit Agreements (1 contract)
- Loan Agreements (7)
- Note Agreements (4)
- Purchase Agreements (4)
- Registration Rights Agreements (2)
- Stock Agreements (2)
- Underwriting Agreements (7)
- Warrant Agreements (5)
- Registration Rights Agreement, dated January 26, 2024, by and among Kura Oncology, Inc. and the persons party thereto (Filed With SEC on January 26, 2024)
- Securities Purchase Agreement, dated January 24, 2024, by and among Kura Oncology, Inc. and the persons party thereto (Filed With SEC on January 26, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 26, 2024)
- First Amendment to Loan and Security Agreement, dated as of October 2, 2023, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on November 2, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 14, 2023)
- Underwriting Agreement, dated June 13, 2023, by and among Kura Oncology, Inc., BofA Securities, Inc., Jefferies LLC and SVB Securities LLC, as representatives of the several... (Filed With SEC on June 14, 2023)
- Loan and Security Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Hercules Capital, Inc (Filed With SEC on November 3, 2022)
- Securities Purchase Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 3, 2022)
- Form of Warrant Agreement issued by Kura Oncology, Inc. on November 2, 2022 to Hercules Capital, Inc. and certain other Lenders (Filed With SEC on November 3, 2022)
- Sales Agreement, dated February 24, 2022, by and among Kura Oncology, Inc., SVB Securities LLC, Credit Suisse Securities (USA) LLC and Cantor Fitzgerald & Co (Filed With SEC on February 24, 2022)
- Amended and Restated Asset Purchase Agreement, dated February 12, 2015, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)
- Underwriting Agreement, dated December 8, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC, Credit Suisse Securities (USA) LLC, Barclays Capital Inc., and Stifel, Nicolaus... (Filed With SEC on December 9, 2020)
- Underwriting Agreement, dated May 5, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on May 6, 2020)
- First Amendment to Loan and Security Agreement, dated April 3, 2020, by and between Kura Oncology, Inc. and Silicon Valley Bank (Filed With SEC on April 7, 2020)
- Description of Registrants Common Stock (Filed With SEC on February 25, 2020)
- Underwriting Agreement, dated June 18, 2019, by and among Kura Oncology, Inc. and SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 19, 2019)
- Loan and Security Agreement, dated as of November 1, 2018, by and among the Registrant and Silicon Valley Bank (Filed With SEC on November 5, 2018)
- Underwriting Agreement, dated June 27, 2018, by and between Kura Oncology, Inc. and Leerink Partners LLC, as representative of the several underwriters named therein (Filed With SEC on June 28, 2018)
- Second Amendment to Loan and Security Agreement, dated October 12, 2017, by and between the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 7, 2017)
- 7,700,000Shares KURA ONCOLOGY, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2017)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 10, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 10, 2016)
- Kura Oncology, Inc. [] Shares1 Common Stock ($0.0001 parvalue) Underwriting Agreement (Filed With SEC on October 28, 2015)
- AMENDED AND RESTATED ASSET PURCHASE AGREEMENT (Filed With SEC on March 12, 2015)
- KURA ONCOLOGY, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 6, 2015 APPROVED BY THE STOCKHOLDERS:MARCH 6, 2015 (Filed With SEC on March 12, 2015)
- KURA ONCOLOGY, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 12, 2015)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)